Pretomanid, Dovprela, Pretomanid FGK (pretomanid) is a small molecule pharmaceutical. Pretomanid was first approved as Pretomanid on 2019-08-14. It is used to treat extensively drug-resistant tuberculosis in the USA. It has been approved in Europe to treat multidrug-resistant tuberculosis.
|Trade Name||Dovprela, Pretomanid FGK|
|Indication||extensively drug-resistant tuberculosis, multidrug-resistant tuberculosis|
|Drug Class||Mycolic acid inhibitors|